Outsourced Vaccine Development - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourced Vaccine Development
The authors discuss how strategic outsourcing to contract manufacturing organizations that have technical and regulatory expertise can add further value during vaccine development.


Pharmaceutical Technology
Volume 33, Issue 7

References

1. Kalorama Information, http://www.kaloramainformation.com/, accessed June 22, 2009.

2. C. Franco, "Billions for Biodefense: Federal Agency Biodefense Funding, FY2008-FY2009," Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 6 (2), page 131 (2008).

3. PhRMA, "Report on Biotechnology Medicines in Development", 2008, http://www.pharma.org/, accessed June 22, 2009.

4. K.J. Morrow, Jr., "Revamping and Reengineering Existing Technology Can Increase Protein Yield and Efficacy," Gen. Engineer. and Biotechnol. News, 27 (5) 50–54 (2007).

5. Y. Durocher et al., "Scalable serum-free Production of Recombinant adeno-associated Virus Type 2 by Transfection of 293 Suspension cells, Journ. of Virolog. Meth., 144, p. 32 (2007).

6. H.R.G. Clarke, and B.J. Compton, "Comparing Mammalian Expression Systems The First Rate-Limiting Step in Making Products for Clinical Testing," supplement to BioProcess Internat., 6 (11) 24–32 (2008).

7. P. Gagnon, "Monoliths Emerge as Key Purification Methodology," Gen. Engineer. and Biotechnol. News, 28 (14) (2008), http://www.genengnews.com/.

8. C. H. Arnaud, "Analyzing Vaccines," Chem. & Engineer. News, 84 (14), P. 52 (2006).

9. C. Scott, "Formulation Development, Making the Medicine," supplement to BioProcess Internat., 42 (3) 42–56, March 2006.

10. A. Sjolander, J.C. Cox, and I.G. Barr, "ISCOMs: An Adjuvant with Multiple Functions," Jour. of Leukocyte Biol., 64, 713–723 (1998).

11. S. Crossman and J. Lawson, "Considerations for Choosing a CMO," Contract Pharm., 10 (2008), http://www.contractpharma.com/


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here